| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.026 | 0.6 |